Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases

Related Experiment Video

Updated: Feb 19, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.6K

Massimo Gentile1, Tait D Shanafelt2,3, Francesca R Mauro4

  • 1Department of Onco-hematology, Hematology Unit, AO of Cosenza, Italy.

American Journal of Hematology
|November 4, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

774

Related Experiment Videos

Last Updated: Feb 19, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

774

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788

Articles linked to this work by shared authors, journal, and citation graph.

Navigating Measurable Residual Disease as a Surrogate Endpoint in Chronic Lymphocytic Leukemia.

Hematological oncology·2026

Host Fitness: A Missing Dimension of Precision Medicine in Older Acute Myeloid Leukemia.

Hematological oncology·2026

Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study.

Hematological oncology·2026

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

British journal of haematology·2026

Latent Epstein-Barr Virus Infection Correlates with Glycosphingolipid Enrichment and Morphological Remodeling of Extracellular Particles.

Biology·2026

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation.

Antibodies (Basel, Switzerland)·2026

Clinical Experience of Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.

American journal of hematology·2026

Integrated Multi-Omic Characterization of Hexokinase-1 Deficiency in Red Blood Cells Reveals Altered Redox Homeostasis, Membrane Remodeling, and Features of Incomplete Erythroid Maturation.

American journal of hematology·2026

Prognostic Impact of FLT3-ITD Allelic Ratio in AML Patients Treated With High-Dose Anthracycline and a FLT3 Inhibitor.

American journal of hematology·2026

Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation.

American journal of hematology·2026

New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification.

American journal of hematology·2026

Outcomes of Patients With AL Amyloidosis and End-Stage Renal Disease After Initiation of Therapy.

American journal of hematology·2026

Predicting recurrence risk after neoadjuvant therapy in breast cancer: a single-center retrospective cohort study integrating residual cancer burden and immune microenvironment features.

Frontiers in oncology·2026

Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.

Frontiers in oncology·2026

Multiparametric MRI radiomics for preoperative prediction of tumor budding grade in rectal cancer.

Frontiers in oncology·2026

IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.

Frontiers in oncology·2026

Diagnostic performance of next-generation sequencing in thyroid nodules and molecular correlates of tumor aggressiveness in papillary thyroid carcinoma.

Frontiers in endocrinology·2026

Multimodal radiomics based on dynamic contrast-enhanced ultrasound for predicting cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us